Wing Tak Wong Selected Research

Neoplasms (Cancer)

1/2023	Risk of diabetes mellitus among users of immune checkpoint inhibitors: A population-based cohort study.
1/2023	Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in Type 2 diabetes mellitus: A population-based study.
1/2023	Association Between Visit-to-Visit Lipid Variability and Incident Cancer: A Population-based Cohort Study.
3/2022	Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis.
12/2005	Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wing Tak Wong Research Topics

Disease

15	Hypertension (High Blood Pressure) 12/2022 - 01/2009
10	Inflammation (Inflammations) 01/2023 - 05/2011
9	Type 2 Diabetes Mellitus (MODY) 01/2023 - 09/2012
7	Stroke (Strokes) 02/2023 - 12/2015
7	Myocardial Infarction 01/2023 - 12/2015
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2009
6	Atherosclerosis 01/2021 - 12/2015
5	Diabetes Mellitus 01/2023 - 04/2014
5	Neoplasms (Cancer) 01/2023 - 12/2005
5	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022 - 01/2017
4	Atrial Fibrillation 01/2023 - 05/2021
4	Heart Failure 01/2023 - 01/2018
3	Infections 10/2022 - 04/2012
3	Insulin Resistance 12/2012 - 07/2010
2	Hemorrhage 11/2023 - 01/2018
2	Ischemic Stroke 11/2023 - 01/2021
2	Ischemia 08/2023 - 01/2019
2	COVID-19 10/2022 - 01/2021
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 11/2021
2	Osteoporosis 05/2021 - 03/2010
2	Dementia (Dementias) 05/2021 - 01/2021
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2021 - 01/2020
2	Ventricular Tachycardia 01/2021 - 10/2017
2	Frailty 01/2018 - 12/2017
2	Atherosclerotic Plaque (Atheroma) 09/2016 - 03/2016
2	Metabolic Diseases (Metabolic Disease) 12/2015 - 01/2010
2	Hyperglycemia 11/2010 - 06/2009
1	Endocarditis 11/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023
1	Thromboembolism 11/2023
1	Syncope (Fainting) 11/2023
1	Gout 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Cardiotoxicity 01/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2022
1	Pancreatic Diseases (Pancreatic Disease) 10/2022
1	Chronic Renal Insufficiency 10/2022

Drug/Important Bio-Agent (IBA)

9	Hypoglycemic Agents (Hypoglycemics)IBA 11/2023 - 04/2014
5	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2023 - 09/2012
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 04/2012
4	Immune Checkpoint InhibitorsIBA 01/2023 - 03/2022
4	LipidsIBA 01/2023 - 01/2021
4	Metformin (Glucophage)FDA LinkGeneric 05/2022 - 04/2014
3	SodiumIBA 11/2023 - 01/2022
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2021
3	CholesterolIBA 01/2023 - 01/2021
3	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2021
3	Insulin (Novolin)FDA Link 01/2022 - 11/2010
3	Uncoupling Protein 2IBA 10/2017 - 04/2012
3	MicroRNAs (MicroRNA)IBA 01/2017 - 03/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 04/2010
3	Vasoconstrictor AgentsIBA 12/2016 - 04/2010
3	AntioxidantsIBA 12/2015 - 04/2010
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2013 - 01/2010
2	Warfarin (Coumadin)FDA LinkGeneric 11/2023 - 01/2018
2	dapagliflozinIBA 11/2023 - 01/2023
2	ertugliflozinIBA 11/2023 - 01/2023
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2021
2	HDL CholesterolIBA 01/2023 - 01/2021
2	CreatinineIBA 12/2022 - 01/2020
2	Urea (Carbamide)FDA LinkGeneric 12/2022 - 01/2011
2	Heptanol (1 Heptanol)IBA 01/2021 - 10/2017
2	Oxygen (Dioxygen)IBA 01/2019 - 12/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 04/2010
2	AngiotensinsIBA 12/2016 - 04/2010
2	E-SelectinIBA 09/2016 - 03/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2015 - 12/2012
2	Sitagliptin Phosphate (Januvia)FDA Link 10/2014 - 09/2012
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 03/2013
2	Oxidoreductases (Dehydrogenase)IBA 03/2013 - 10/2010
2	NADP (NADPH)IBA 03/2013 - 10/2010
2	Rosiglitazone (Avandia)FDA Link 07/2011 - 11/2010
2	Protein Kinases (Protein Kinase)IBA 05/2011 - 06/2009
2	Angiotensin IIIBA 05/2011 - 04/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2011 - 10/2010
2	Endothelin-1 (Endothelin 1)IBA 01/2011 - 04/2010
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2010 - 06/2009
2	Arachidonic Acid (Vitamin F)IBA 04/2010 - 01/2010
1	Cardiovascular AgentsIBA 11/2023
1	CanagliflozinIBA 11/2023
1	empagliflozinIBA 11/2023
1	CytokinesIBA 08/2023
1	Serum AlbuminIBA 02/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	LDL CholesterolIBA 01/2023
1	protocatechuic acidIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Fibric Acids (Fibrates)IBA 01/2023
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2022
1	Acarbose FDA LinkGeneric 10/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2022
1	VaccinesIBA 10/2022
1	COVID-19 VaccinesIBA 10/2022
1	NivolumabIBA 03/2022
1	pembrolizumabIBA 03/2022
1	atezolizumabIBA 03/2022
1	B7-H1 AntigenIBA 03/2022

Therapy/Procedure

10	Therapeutics 11/2023 - 04/2010